期刊文献+

血清及脑脊液S100蛋白和降钙素原诊断颅内感染的价值 被引量:14

Values of S100 protein and procalcitonin in serum and cerebrospinal fluid to the diagnosis of intracranial infection
原文传递
导出
摘要 目的探讨血清及脑脊液S100蛋白、降钙素原(procalcitonin,PCT)在颅内感染诊断中的应用价值。方法颅内感染患者91例,其中细菌性脑炎患者43例(细菌性脑炎组),病毒性脑炎患者48例(病毒性脑炎组);同期38例癫痫患者为对照组。采用ELISA法检测3组入院48h内血清及脑脊液S100蛋白水平,电化学发光免疫法检测血清及脑脊液PCT水平;绘制ROC曲线分析血清及脑脊液S100蛋白、PCT鉴别诊断细菌性脑炎、病毒性脑炎的效能。结果病毒性脑炎组、细菌性脑炎组血清S100蛋白[(21.24±8.32)、(50.91±11.55)μg/L]、脑脊液S100蛋白[(14.60±6.45)、(40.38±8.05)μg/L]水平高于对照组[(0.24±0.10)、(2.16±0.72)μg/L],血清PCT[(0.38±0.12)、(0.89±0.22)μg/L]、脑脊液PCT[(0.19±0.09)、(0.76±0.20)μg/L]水平高于对照组[(0.23±0.09)、(0.09±0.03)μg/L](P<0.05),且细菌性脑炎组高于病毒性脑炎组(P<0.05);血清、脑脊液S100分别以36.19、28.51μg/L为最佳截断值,鉴别诊断细菌性脑炎与病毒性脑炎的AUC分别为0.972(95%CI:0.942~1.000,P<0.001)、0.994(95%CI:0.981~1.000,P<0.001),灵敏度分别为90.7%、97.7%,特异度分别为95.8%、97.9%;血清、脑脊液PCT分别以0.56、0.46μg/L为最佳截断值,鉴别诊断细菌性脑炎与病毒性脑炎的AUC分别为0.968(95%CI:0.924~1.000,P<0.001)、0.998(95%CI:0.993~1.000,P<0.001),灵敏度分别为93.0%、97.7%,特异度分别为95.8%、97.9%。结论颅内感染患者血清及脑脊液S100蛋白、PCT水平均升高,检测血清及脑脊液S100蛋白、PCT水平有助于细菌性脑炎与病毒性脑炎的鉴别诊断。 Objective To investigate the applications of S100 protein and procalcitonin(PCT)in serum and cerebrospinal fluid in the diagnosis of intracranial infection.Methods Ninety-one patients with intracranial infection were divided into 43 patients with bacterial encephalitis(bacterial encephalitis group)and 48 patients with viral encephalitis(viral encephalitis group)while another 38 patients with epilepsy were as controls(control group).The levels of S100 protein and PCT in serum and cerebrospinal fluid were detected by ELISA and electrochemiluminescence immunoassay respectively,and ROC was drawn to analyze the efficacies of S100 protein and PCT in serum and cerebrospinal fluid on differentiating bacterial encephalitis from viral encephalitis.Results The levels of S100protein(serum:(21.24±8.32),(50.91±11.55)μg/L;cerebrospinal fluid:(14.60±6.45),(40.38±8.05)μg/L)and PCT(serum:(0.38±0.12),(0.89±0.22)μg/L;cerebrospinal fluid:(0.19±0.09),(0.76±0.20)μg/L)in viral encephalitis group and bacterial encephalitis group were significantly higher than those in control group(S100protein:(0.24±0.10),(2.16±0.72)μg/L;PCT:(0.23±0.09),(0.09±0.03)μg/L)(P<0.05),and higher in bacterial encephalitis group than those in viral encephalitis group(P<0.05).When the optimal cut-offvalues of S100 protein in serum and cerebrospinal fluid were 36.19 and 28.51μg/L,respectively,the AUCs for bacterial encephalitis and viral encephalitis were 0.972(95%CI:0.942-1.000,P<0.001)and 0.994(95%CI:0.981-1.000,P<0.001),the sensitivities were 90.7% and 97.7%,and the specificities were 95.8% and 97.9%,respectively;when the optimal cut-off values of PCT in serum and cerebrospinal fluid were 0.56 and 0.46μg/L,the AUCs for bacterial encephalitis and viral encephalitis were 0.968(95%CI:0.924-1.000,P<0.001)and 0.998(95%CI:0.993-1.000,P<0.001),the sensitivities were 93.0% and 97.7%,and the sensitivities were 95.8% and 97.9%,respectively.Conclusion The levels of S100 protein and PCT in serum and cerebrospinal fluid increase in patients with intracranial infection,and the detection of them contributes to the differential diagnosis of bacterial encephalitis and viral encephalitis.
作者 李时光 刘新生 王昆 罗小娜 张瑞锋 陈江波 冯丽君 LI Shiguang;LIU Xinsheng;WANG Kun;LUO Xiaona;ZHANG Ruifeng;CHEN Jiangbo;FENG Lijun(Department of Neurology,the First People's Hospital of Zhengzhou,Zhengzhou 450004,China)
出处 《中华实用诊断与治疗杂志》 2019年第1期56-58,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 郑州市科技发展计划项目(2015005)
关键词 颅内感染 S100蛋白 降钙素原 细菌性脑炎 病毒性脑炎 intracranial infection S100protein procalcitonin bacterial encephalitis viral encephalitis
  • 相关文献

参考文献11

二级参考文献124

  • 1徐波,刘励军.血清降钙素原(PCT)的动态变化对感染性休克预后的意义[J].中国血液流变学杂志,2008,18(1):99-101. 被引量:10
  • 2徐裕海,李桂新,刘谦慧.感染性休克体液复苏治疗后C反应蛋白和降钙素原动态变化的研究[J].大连医科大学学报,2009,31(1):95-97. 被引量:30
  • 3苏赞彩,黄志敏,王优,黄秀兰.不同病原体脑病患儿血浆降钙素原改变的临床意义[J].中国综合临床,2005,21(1):79-80. 被引量:14
  • 4王鹏高,施新革,赵文增.心内直视手术患者血浆S100β蛋白变化的意义[J].医药论坛杂志,2005,26(1):37-38. 被引量:1
  • 5Nobre V, Harbarth S, Graf J D, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients [J]. Respir Crit Care Med,2008,177(1) :498-505.
  • 6Svoboda P, Kantorovci I, Scheer P, etal. Can procalcitonin help us in timing ot re-intervention in septic patients after multiple trauma or major surgery[J]. Hepatogastroenterology, 2007,54 (74):359- 363.
  • 7Charles P E, Dalle F, Aho S, et al. Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients[J]. Intensive Care Med, 2006, 32(10): 1577 -1583.
  • 8Suprin E, Camus C, Gacouin A, etal. Procalcitonin: a valuable indicator of infection in a medical ICU[J]. Intensive Care Med, 2000,26(9) :1232-1238.
  • 9Giamarellos Bourboulis E J, Grecka P, Poulakou G, et al. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenial[J].Clin Infect Dis,2001,32(12) : 1718-1725.
  • 10Tang B M, Eslick G D, Craig J C, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis[J]. Lancet Infect Dis, 2007,7(3) :210-217.

共引文献190

同被引文献136

引证文献14

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部